John Dickerson, Maurice DuBois in for Norah O’Donnell at CBS

US

Veteran newsmen John Dickerson and Maurice DuBois will host “CBS Evening News” when Norah O’Donnell leaves the show after the November election.

The network announced Thursday that changing of the guard will coincide with the program’s move from Washington D.C. to New York City in the fall.

“We want to thank Norah for her exceptional work on the Evening News over the past five years, and we are grateful she has decided to continue leading our coverage through the election,” president and CEO of CBS News Wendy McMahon said in a statement also naming “60 Minutes” executive producer Bill Owens as CBS Evening News’ incoming supervising producer.

CBS said O’Donnell will lead the network’s political coverage through the election before taking on her new role as the network’s senior news correspondent. The 50-year-old Washington D.C. native, who took over the evening desk in 2019 after working mornings at CBS, told her colleagues she was making a change in a Wednesday email.

“I have spent 12 years in the anchor chair here at CBS News, connected to a daily broadcast and the rigors of a relentless news cycle,” she wrote. “It’s time to do something different.”

CBS News described the revamped version of its evening program as an ensemble effort that will include “Face the Nation” moderator Margaret Brennan reporting from the nation’s capital.

CBS Evening News has struggled to keep pace with its competition at ABC and NBC.

“ABC World News Tonight with David Muir” averaged 7.590 million total viewers for the Week of July 22, according to AdWeek. “NBC Nightly News” reportedly finished second with an average of 6.188 million watchers. An average of 4.383 million viewers tuned in to O’Donnell on CBS News last week.

Products You May Like

Articles You May Like

California Map Shows Plan For Automated Rail System
Carruba Liqueur: What to Know About Monaco’s Unique Carob Liqueur
Sam Rubin receives posthumous honor at 76th Los Angeles Area Emmy Awards 
First Solar tops second-quarter estimates but leaves forecast unchanged amid election uncertainty
What to know about the FDA-approved blood test for colon cancer detection

Leave a Reply

Your email address will not be published. Required fields are marked *